Merck pens $500M Yumanity pact, nabbing two neuro hopefuls in the process. Will the collaboration beef up $MRK’s #neurology pipeline after the company left behind its Alzheimer’s program? https://t.co/DcSD3ZCIaa https://t.co/cAU16G0uIq